Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

• Author(s): Simonelli, C.
• Date: 2015
• Origin: Oasisbr
• Subject(s): DOENÇAS HEMATOLÓGICAS
• Document Type: Journal article
• Language: English